Pioglitazone: An Ongoing Misery in the Developing Countries to Which I can’t be Pragmatic!

Journal Title: Open Access Journal of Endocrinology - Year 2018, Vol 2, Issue 2

Abstract

In 2014, I've published an article warning against the widespread usage of pioglitazone in the developing countries though it has been banned or heavily restricted in all developed countries due to its proved causation with an increased incidence of bladder carcinoma

Authors and Affiliations

Mina T Kelleni

Keywords

Related Articles

Gestational Diabetes Mellitus and Ademolus Classification of Hypoglycaemia-A Review

According to the World Health Organization, hyperglycaemia first detected at any time during pregnancy should be classified as either diabetes mellitus in pregnancy, or gestational diabetes mellitus. Current definitions...

Spectrum of Diabetic Kidney Disease in India - A Tertiary Care Centre Experience

Objectives / Aim of study: To assess the magnitude, clinico-social risk factors and associations of diabetic kidney disease in type 2 diabetes subjects attending a tertiary care centre in Eastern India. Materials and Me...

Thyrotoxicosis Associated Channelopathy

We hereby report a case of 47 year-old man of Indian origin whose hyperthyroidism surfaced when he presented with an episode of muscular paralysis in association with hypokalemia. Weakness recovered with the correction o...

Is there an Escalation of Type 2 Diabetes Mellitus in Children and Adolescents: Therapeutics and Preventive Approach

There is an increasing prevalence of type 2 diabetes mellitus (T2DM) in children and adolescents from all over the world from various ethnicities, although the incidence of obesity is not increasing any more. Most of the...

Is it Useful to Perform FNAC in Thyroid Gland Diseases?

Background: Neck masses are usually benign, their clinical importance is primarily related to the need to exclude thyroid cancer Thyroid gland cancer accounts for 1% of all cancers and is responsible for 0.5% of death re...

Download PDF file
  • EP ID EP448891
  • DOI 10.23880/oaje-16000122
  • Views 59
  • Downloads 0

How To Cite

Mina T Kelleni (2018). Pioglitazone: An Ongoing Misery in the Developing Countries to Which I can’t be Pragmatic!. Open Access Journal of Endocrinology, 2(2), 1-2. https://europub.co.uk./articles/-A-448891